Exclusive

Publication

Byline

Location

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More


Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More


Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More


Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More


Lay's(R) Turns its INR 20 Pack into a Chance to Meet Ranbir Kapoor

India, Sept. 27 -- With its new 'Lay's(R) Kholo, Ranbir Se Milo' contest, the brand is giving fans a chance to win rewards worth INR 2 crore*, including an opportunity to meet Ranbir Kapoor. National... Read More


Bigg Boss 20: आप बदतमीज हैं और..., सलमान खान के सामने ही माही विज ने इस कंटेस्टेंट की निकाली हेकड़ी, देखते रह गए भाई जान

नई दिल्ली, सितम्बर 27 -- Bigg Boss 20: बॉलीवुड सुपरस्टार सलमान खान का शो 'बिग बॉस 20' इस वक्त काफी सुर्खियों में बना हुआ है। 'बिग बॉस 20' के घर का माहोल इस वक्त पूरी तरह से गरमाया हुआ है। ये शो शुरू ह... Read More


10 missing after avalanche hits Himlung Himal

Nepal, Sept. 27 -- Ten people, including climbers and support staff, are unaccounted for after an avalanche struck Himlung Himal, a 7,126-metre peak in the Nar Phu area of Manang district. Rishi Bhan... Read More


Railways eyes smart waste-compactor bins at busy stations to curb overflowing litter

Panchkula, Sept. 27 -- The Railway Board has asked all zonal railways to consider deploying waste-compactor smart bins at high-footfall railway stations on an experimental basis, seeking a technology-... Read More